Biblio
Export 1476 results:
Author [ Title
Filters: First Letter Of Last Name is K [Clear All Filters]
“Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1061-1076, 2018.
, “Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1061-1076, 2018.
, “Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1061-1076, 2018.
, “Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.”, J Alzheimers Dis, vol. 75, no. 1, pp. 173-185, 2020.
, “Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.”, J Alzheimers Dis, vol. 75, no. 1, pp. 173-185, 2020.
, “Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.”, J Alzheimers Dis, vol. 75, no. 1, pp. 173-185, 2020.
, “Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.”, J Alzheimers Dis, vol. 83, no. 1, pp. 355-366, 2021.
, “Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.”, J Alzheimers Dis, vol. 83, no. 1, pp. 355-366, 2021.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “Supplementation with Matured Hop Bitter Acids Improves Cognitive Performance and Mood State in Healthy Older Adults with Subjective Cognitive Decline.”, J Alzheimers Dis, vol. 76, no. 1, pp. 387-398, 2020.
, “Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study.”, J Alzheimers Dis, vol. 93, no. 2, pp. 561-575., 2023.
, “Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project.”, J Alzheimers Dis, 2018.
, “Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 1, pp. 165-174, 2018.
, “Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 1, pp. 165-174, 2018.
, “Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 1, pp. 165-174, 2018.
, “Subjective Cognitive Decline Prediction of Mortality: Results from the Einstein Aging Study.”, J Alzheimers Dis, vol. 66, no. 1, pp. 239-248, 2018.
, “Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1469-1478, 2019.
, “Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1469-1478, 2019.
, “Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1469-1478, 2019.
, “Subjective Cognitive Complaints in Cognitively Healthy Older Adults and Their Relationship to Cognitive Performance and Depressive Symptoms.”, J Alzheimers Dis, vol. 59, no. 3, pp. 871-881, 2017.
, “STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 51, no. 2, pp. 391-403, 2016.
, “A Study of a Supplement Containing Huperzine A and Curcumin in Dementia Patients and Individuals with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 63, no. 1, pp. 75-78, 2018.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
,